Journal article
Vesicular stomatitis virus: re-inventing the bullet
Abstract
As our understanding of the molecular aspects of human disease increases, it is becoming possible to create designer therapeutics that are exquisitely targeted and have greater efficacy and fewer side effects. One class of targeted biological agents that has benefited from recent advances in molecular biology is designer viruses. Vesicular stomatitis virus (VSV) is normally relatively innocuous but can be engineered to target cancer cells or to …
Authors
Lichty BD; Power AT; Stojdl DF; Bell JC
Journal
Trends in Molecular Medicine, Vol. 10, No. 5, pp. 210–216
Publisher
Elsevier
Publication Date
May 2004
DOI
10.1016/j.molmed.2004.03.003
ISSN
1471-4914